Inhibition of the diuretic action of glibenclamide by clofibrate, carbamazepine and 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
D001120:Arginine / Q000627:therapeutic use*; D002220:Carbamazepine / Q000627:therapeutic use*; D002994:Clofibrate / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000188:drug therapy*; D004231:Diuresis / Q000187:drug effects*; D004347:Drug Interactions; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D014667:Vasopressins / Q000627:therapeutic use*
D014667:Vasopressins; D002220:Carbamazepine; D001120:Arginine; D002994:Clofibrate; D005905:Glyburide